Fagområder
Statistikk
Faglig bakgrunn
PhD i statistisk modellering av medisinske bildedata; postdoktorell forskning med utvikling av statistiske metoder for å evaluere effekten av nye legemidler (spesielt kreftbehandlinger); kommersiell erfaring med å jobbe med globale farmasøytiske selskaper.
Prosjekter og publikasjoner
- Matt Oxman, Giordano Perez-Gaxiola, Dima Alsaid, Anila Qasim, Christopher James Rose, Karin Bischoff, Andrew David Oxman, (2021). Quality of information in news media reports about the effects of health interventions: Systematic review and meta-analyses. F1000Research doi: 10.12688/f1000research.52894.1
- Unni Solveig Johansen Olsen, Maren Falch Lindberg, Eva Marie-Louise Denison, Christopher James Rose, Caryl Gay, Arild Aamodt, Jens Ivar Brox, Øystein Skare, Ove Furnes, Kathryn A Lee, Anners Lerdal, (2020). Predictors of chronic pain and level of physical function in total knee arthroplasty: a protocol for a systematic review and meta-analysis. BMJ Open s. 1-9. doi: 10.1136/bmjopen-2020-037674
- Daniel Semakula, Allen Nsangi, Andrew David Oxman, Matt Oxman, Astrid Dahlgren, Sarah Ellen Rosenbaum, Angela Morelli, Claire Glenton, Simon Arnold Lewin, Laetitia Nyirazinyoye, Margaret Kaseje, Iain Chalmers, Atle Fretheim, Christopher James Rose, Nelson K. Sewankambo, (2020). Effects of the Informed Health Choices podcast on the ability of parents of primary school children in Uganda to assess the trustworthiness of claims about treatment effects: one-year follow up of a randomised trial. Trials doi: 10.1186/s13063-020-4093-x
- Daniel Semakula, Allen Nsangi, Andrew David Oxman, Claire Glenton, Simon Arnold Lewin, Sarah Ellen Rosenbaum, Matt Oxman, Margaret Kaseje, Astrid Dahlgren, Christopher James Rose, Atle Fretheim, Nelson Sewankambo, (2019). Informed Health Choices media intervention for improving people's ability to critically appraise the trustworthiness of claims about treatment effects: A mixed-methods process evaluation of a randomised trial in Uganda. BMJ Open doi: 10.1136/bmjopen-2019-031510
- Allen Nsangi, Daniel Semakula, Claire Glenton, Simon Arnold Lewin, Andrew David Oxman, Matt Oxman, Sarah Ellen Rosenbaum, Astrid Dahlgren, Laetitia Nyirazinyoye, Margaret Kaseje, Christopher James Rose, Atle Fretheim, Nelson K. Sewankambo, (2019). Informed health choices intervention to teach primary school children in low-income countries to assess claims about treatment effects: process evaluation. BMJ Open s. 1-13. doi: 10.1136/bmjopen-2019-030787
- James O'Connor, Christopher James Rose, (2015). Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome. Clinical Cancer Research doi: 10.1158/1078-0432.CCR-14-0990
- James O’Connor, Christopher James Rose, A Jackson, Yvonne Watson, C Roberts, Giovanni Buonaccorsi, G. Thompson, Andrew Clamp, GC Jayson, GJM Parker, (2011). DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6. British Journal of Cancer doi: 10.1038/bjc.2011.191
- Samantha J. Mills, Calvin Soh, James O’Connor, Christopher James Rose, Giovanni Buonaccorsi, Sue Cheung, GJM Parker, A Jackson, (2010). Enhancing Fraction in Glioma and Its Relationship to the Tumoral Vascular Microenvironment: A Dynamic Contrast-Enhanced MR Imaging Study. American Journal of Neuroradiology doi: 10.3174/ajnr.A1925
- Samantha J. Mills, Christina Soh, Christopher James Rose, GJM Parker, A Jackson, (2010). Candidate Biomarkers of Extravascular Extracellular Space: A Direct Comparison of Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced MR Imaging—Derived Measurement of the Volume of the Extravascular Extracellular Space in Glioblastoma Multiforme. American Journal of Neuroradiology doi: 10.3174/ajnr.A1844
- Christopher James Rose, Samantha J. Mills, James O’Connor, Giovanni Buonaccorsi, (2009). Quantifying spatial heterogeneity in dynamic contrast‐enhanced MRI parameter maps. Magnetic Resonance in Medicine doi: 10.1002/mrm.22003
- James O’Connor, Andrew Clamp, Jed Ross, Calvin Ho, Christopher James Rose, Karen Davies,, Gordon C. Jayson, (2009). Quantifying Antivascular Effects of Monoclonal Antibodies to Vascular Endothelial Growth Factor: Insights from Imaging. Clinical Cancer Research doi: 10.1158/1078-0432.CCR-09-0731
- C Roberts, GJM Parker, Christopher James Rose, Yvonne Watson, James O’Connor, Stavros Stivaros, A Jackson, (2008). Glandular Function in Sjögren Syndrome: Assessment with Dynamic Contrast-enhanced MR Imaging and Tracer Kinetic Modeling—Initial Experience. Radiology doi: 10.1148/radiol.2463070298
- James O’Connor, Gordon C. Jayson, A Jackson, Dana Ghiorghiu, Christopher James Rose, Samantha J. Mills, C Roberts, GJM Parker, (2007). Enhancing Fraction Predicts Clinical Outcome following First-Line Chemotherapy in Patients with Epithelial Ovarian Carcinoma. Clinical Cancer Research doi: 10.1158/1078-0432.CCR-07-0331
- James O’Connor, A Jackson, Giovanni Buonaccorsi, DL Buckley, C. Roberts,, Yvonne Watson, D McGrath, Christopher James Rose, Paul M Dark, G Jayson, GJM Parker, (2007). Organ‐specific effects of oxygen and carbogen gas inhalation on tissue longitudinal relaxation times. Magnetic Resonance in Medicine doi: 10.1002/mrm.21357
- Tariq Aslam, Christopher James Rose, (2006). OSCA: a comprehensive open-access system of analysis of posterior capsular opacification. BMC Ophthalmology doi: 10.1186/1471-2415-6-30
- Christopher James Rose, D Turi, Alan Williams, Christopher Taylor, (2006). Web Services for the DDSM and Digital Mammography . Lecture Notes in Computer Science (LNCS) doi: 10.1007/11783237_51
- Jose Francisco Meneses Echavez, Asbjørn Steiro, Christopher James Rose, Hilde Tinderholt Myrhaug, Heid Nøkleby, Johan Siqveland, (2020). Education to improve labor market opportunities: a systematic review
- Christopher James Rose, Unni Olsen, Maren Falch Lindberg, Eva Marie-Louise Denison, Arild Aamodt, Anners Lerdal, (2020). A new multivariate meta-analysis model for many variates and few studies
- Ingrid Kristine Ohm, Torunn Elisabeth Tjelle, Christopher James Rose, Vida Hamidi, Gunhild Hagen, Atle Fretheim, (2020). Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment
- Torunn Elisabeth Tjelle, Christopher James Rose, Ingrid Kristine Ohm, Eva Flovild Pike, Lise Lund Håheim, Julia Bidonde, Atle Fretheim, Lene Kristine Juvet, (2019). Disease-modifying treatments for relapsing remitting multiple sclerosis, including rituximab. A health technology assessment.
- Gunhild Hagen, Hannisdahl Elisabeth, Christopher James Rose, Therese Kristine Dalsbø, (2020). Hvor effektive er legemidler til behandling av plakkpsoriasis?. Sykepleien Forskning doi: 10.4220/Sykepleienf.2020.81878